Introduction to Serratia Marcescens Infections in Neonates
Serratia marcescens, a Gram-negative bacillus, has increasingly emerged as a significant pathogen in neonatal intensive care units (NICUs), particularly affecting preterm infants. It is known for its opportunistic nature, leading to severe neonatal sepsis and other complications in vulnerable populations. This retrospective observational case series, conducted at the Mohammed V Military Teaching Hospital in Rabat, Morocco, sought to analyze cases of bloodstream infections attributed to S. marcescens between August 2024 and August 2025. The study aimed to elucidate clinical, laboratory, and microbiological aspects of the infections, providing valuable insights into the management and prevention of such cases in the NICU setting.
Findings and Implications of the Study
Throughout the study period, 377 neonates were admitted to the NICU, with 16 (4.2% of admissions) diagnosed with culture-confirmed S. marcescens sepsis. Alarmingly, a significant portion of these neonates—75%—were born prematurely, before 34 weeks of gestation, and 56.3% had a birth weight below 1,500 grams. The predominant clinical signs included respiratory distress and hemodynamic instability, with many patients exhibiting elevated C-reactive protein levels and thrombocytopenia. Notably, the overall mortality rate among the affected infants reached a staggering 43.8%, underscoring the severity of these infections. This case series highlights the urgent need for timely microbiological diagnoses and susceptibility-guided treatment regimens. Furthermore, it emphasizes the importance of rigorous infection prevention protocols, especially in high-risk populations, to mitigate the impact of such opportunistic infections.
As reported by cureus.com.
